CombiMatrix Regains Compliance With Nasdaq Min. Stockholders' Equity Requirement

(RTTNews) - CombiMatrix Corp.(CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, announced that in a letter dated August 20, 2013, from the Director of Listing Qualifications of The Nasdaq Stock Market LLC, the company was informed that it has regained compliance with Listing Rule 5550(b)(1), which requires a minimum of $2.5 million stockholders' equity for The Nasdaq Capital Market.

The letter from Nasdaq said that based on the company's Form 10-Q for the period ended June 30, 2013, which evidenced stockholders' equity of $5.7 million, the Nasdaq Staff has determined that CombiMatrix complies with the Rule and "the matter is now closed."